
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.276243093923 | 3.62 | 4.1186 | 3.32 | 1102475 | 3.78186532 | CS |
4 | 0.02 | 0.554016620499 | 3.61 | 4.1186 | 2.6 | 822283 | 3.43156323 | CS |
12 | -0.35 | -8.79396984925 | 3.98 | 4.18 | 2.6 | 841980 | 3.53538768 | CS |
26 | 0.99 | 37.5 | 2.64 | 7.27 | 2.59 | 1150741 | 4.22163412 | CS |
52 | 0.24 | 7.0796460177 | 3.39 | 7.27 | 1.575 | 1437826 | 2.97792541 | CS |
156 | -22.21 | -85.9520123839 | 25.84 | 41.9297 | 1.575 | 1362321 | 14.15862797 | CS |
260 | -17.37 | -82.7142857143 | 21 | 41.9297 | 1.575 | 1309180 | 14.31704339 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions